GVS
870976
Hangzhou CNCR-IT
300250
Shanghai Newtouch Software
688590
Ucap Cloud Information Technology Co.,Ltd
688228
Yangtze Optical Electronic
688143
CN Stock MarketDetailed Quotes
603233 DaShenLin Pharmaceutical Group
- 13.87
- +0.16+1.17%
Market Closed Jan 24 15:00 CST
15.80BMarket Cap18.57P/E (TTM)
13.88High13.61Low54.13KlotVolume13.72Open13.71Pre Close74.75MTurnover0.48%Turnover Ratio13.54P/E (Static)1.14BShares26.4852wk High2.36P/B15.80BFloat Cap11.6152wk Low15.08Limit Up1.14BShs Float59.70Historical High12.34Limit Down1.97%Amplitude8.34Historical Low0.62Dividend TTM13.81Avg Price21.06KlotAsk4.47%Div YieldTTM100Lot Size32.58KlotBid
DaShenLin Pharmaceutical Group News
Announcement of Dashenlin Pharmaceutical Group Co., Ltd. on cancellation of pledge and re-pledge of part of the controlling shareholder\'s shares
Dashanlin: Announcement of Dashenlin Pharmaceutical Group Co., Ltd. on not revising the conversion price of “Dashenlin Bonds” downwards
Dashenlin: Announcement of Resolutions of the 24th Meeting of the Fourth Board of Directors of Dashenlin Pharmaceutical Group Co., Ltd.
Announcement of Resolutions of the 24th Meeting of the Fourth Board of Directors of Dashenlin Pharmaceutical Group Co., Ltd.
Announcement of Dashenlin Pharmaceutical Group Co., Ltd. on not revising the conversion price of “Dashenlin Bonds” downward
Dashanlin: Announcement of Dashenlin Pharmaceutical Group Co., Ltd. on changing the sponsor representative for continuous supervision
Announcement of Dashenlin Pharmaceutical Group Co., Ltd. on changing the sponsor representative for continuous supervision
Dashanlin: Announcement of Dashanlin Pharmaceutical Group Co., Ltd. on the progress of litigation
Dashenlin: Announcement of Dashenlin Pharmaceutical Group Co., Ltd. on the results of the resale of “Dashenlin Bonds”
Announcement of Dashenlin Pharmaceutical Group Co., Ltd. on the progress of litigation
Announcement of Dashenlin Pharmaceutical Group Co., Ltd. on the results of the resale of “Dashen Convertible Bonds”
Dashenlin: An indicative announcement by Dashenlin Pharmaceutical Group Co., Ltd. on the expected “Dashenlin Bonds” to meet the conversion price correction conditions
Dashenlin: Announcement of Dashenlin Pharmaceutical Group Co., Ltd. on the cancellation of the pledge of some of the controlling shareholder\'s shares
An indicative announcement by Dashenlin Pharmaceutical Group Co., Ltd. on the “Dashen Convertible Bonds” expected to meet the revised conditions for the share conversion price
Announcement of Dashenlin Pharmaceutical Group Co., Ltd. on the cancellation of the pledge of some of the controlling shareholder\'s shares
Dashenlin: Third indicative announcement of Dashenlin Pharmaceutical Group Co., Ltd. on the resale of “Dashenlin Convertible Bonds”
Third indicative announcement of Dashenlin Pharmaceutical Group Co., Ltd. on the resale of “Dashen Convertible Bonds”
Dashenlin: Second indicative announcement of Dashenlin Pharmaceutical Group Co., Ltd. on the resale of “Dashenlin Convertible Bonds”
Second indicative announcement of Dashenlin Pharmaceutical Group Co., Ltd. on the resale of “Dashen Convertible Bonds”
Announcement of Dashenlin Pharmaceutical Group Co., Ltd. on the company\'s controlling shareholder\'s share pledge